Glucocorticoids Drug Metabolism | Sciences Dissertations
The Role of Glucocorticoid Receptor in the Regulation of Drug Metabolism
Glucocorticoids are extremely important in our life due to their pivotal roles in maintaining homeostasis and coping with stress. Tremendous attention has focused on glucocorticoids because of their wide usage in the treatment of autoimmune and inflammatory diseases and their implications to the pathogenesis of many wide-spread disorders, such as hypertension, diabetes, obesity, etc. Many pathophysilogical effects of glucocorticoids are contributed by their transcriptional regulation of approximately 10% of our genes (Buckingham, 2006) and these effects are predominantly dependent on the interaction between glucocorticoids and the glucocorticoid receptor (GR), a ligand-activated transcription factor.
Although a variety of physiological functions, such as immune response, metabolism, growth, etc, could be closely related to the GR-mediated gene regulation, this review will mainly focus on the GR-mediated enzyme regulation and its crucial role on drug metabolism in human.
It has been appreciated that nuclear receptors play important role in xenobiotic response by regulating expression and/or activity of drug-metabolizing enzymes, thereby modifying the targeted concentrations of the drug and altering the therapeutic drug response. With the development of molecular biology, structure biology, genetics and metabolism studies, tremendous effort has been made to understand the fundamental functions of nuclear receptor superfamily, which makes up a complex regulatory network with extensive cross communication in regulating the xenobiotic response between them.
GR becomes my focus not only because of the essential physiological process aforementioned but the key role it plays in drug metabolism. Exploring and understanding the fundamental mechanisms underpinning the actions of GR is critical and is of great help to explain the drug response and some pathophysilogical effects of glucocorticoids as well.
Glucocorticoid receptor belongs to subfamily 3C of nuclear receptor superfamily and is the first cloned human steroid receptor (Hollenberg et al., 1985). Two protein isoforms of GR, termed hGR alpha (777 amino acids) and hGR beta (742 amino acids) are distinguished by the last 15 amino acids at the C-terminal end and differed binding properties with glucocorticoids. hGR alpha is transcriptionally active while hGR beta is unable to bind glucocorticoids or induce gene transcription. Some studies suggest that it may act as a negative regulator of glucocorticoid action and contribute the tissue sensitivity to glucocorticoids (Bamberger et al., 1995).
Three major functional domains: N-terminal domain (NTD), DNA binding domain (DBD) and ligand-binding domain (LBD) are well studied for the GR. Within N-terminal domain, a major activational function domain1 (AF1) is required to enhance maximal transcriptional activity. The DBD contains the most conserved amino acid sequence and comprises two cysteine-rich zinc fingers, which are essential for GR dimerisation and site-specificity of DNA binding. The C-terminal located LBD is responsible for recognition and ligand binding.
It also contains the other activational function domain2 (AF2) and this AF2 is also important in regulating the transcriptional activity of GR. In addition to the three major domains, a D-domain or hinge region links DBD and LBD is considered playing a role in GR nuclear translocation (Kumar and Thompson, 2005; Buckingham, 2006). Recent progresses in crystallographic studies solve the crystal structure of the DBD and LBD of the GR, which reveal more insights into the structure: function relationship of GR and help to better understand the importance of molecular organization in the transcriptional activity as well (Lu et al., 2006).
GR: activation and gene regulation
A chain of impressive reactions occur during the activation of GR and resulting gene regulation. As a ligand-activated transcription factor, the cytoplasm located inactive GR is bound to heat shock protein 90 (hsp90) and other proteins which prevent the nuclear localization of this unoccupied GR. After binding to specific ligand, such as glucocortcoids, the GR is activated and dissociate the oligomeric protein complex, undergoing nuclear translocation, dimerizing via the essential DBD, binding with glucocorticoid response elements (GREs) in the promoter region, recruiting and interacting with other regulatory proteins to induce or repress the expression of targeted genes (Hayashi et al., 2004; Buckingham, 2006).
In addition to the direct regulate gene transcription by activated GR binding with GREs, some recent research suggest the indirect regulatory role of GR via protein-protein interactions (Buckingham, 2006). In this manner, GR could interact with other transcription factors, such as NF-ĸB and AP-1, to reduce the expression of pro-inflammatory genes. Most notably in drug metabolism, an extensive cross-talk between GR and other nuclear receptors exists, such as pregnane X receptor (PXR), constitutive androstane receptor (CAR) and retinoic X receptor (RXR) and it further complicates the GR-mediated gene regulation and drug response (Pascussi et al., 1999; Pascussi et al., 2000b; Pascussi et al., 2004; Dvorak et al., 2005).
Role of GR: Cytochrome P450 3A4
CYP3A4 is the most important and abundant cytochrome p450 in human liver. It has the largest range of substrates and plays a pivotal role in steroid catabolism and xenobiotic metabolism. The fundamental mechanism underlying the transcriptional activation of CYP3A4 is complex and involves many nuclear receptors, such as PXR, GR, vitamin D receptor and CAR. In fact, several observations indicate the important role of GR in the inducible gene expression of CYP3A4. First of all, glucocortcoids are the classic inducers of CYP3A4 in mammals; secondly, RU486, an antagonist of GR, block the dexamethasone-mediated transcriptional activation of CYP3A4 in HepG2 cells cotransfected with GR and CYP3A4 promoter (Ogg et al., 1999).
Although CYP3A4 is highly inducible by glucocortcoids, there’s few evidence for the direct interaction of GR with the CYP3A4 promoter since no consensus glucocorticoid receptor response element (GRE) existed in CYP3A genes. Several possible hypotheses account for the role of GR in the transcription regulation of CYP3A4 have been projected (El-Sankary et al., 2002). Either a nonconsensus GRE present in the CYP3A4 promoter region could be used to explain the direct interaction of GR with the CYP3A4 promoter or as previously mentioned via an indirect manner, GR could interact with other transcription factors thereby interacting with the CYP3A4 promoter to induce CYP3A4. Opposed to these hypotheses, study from a GR-knockout mice model shows that GR is not essential for the glucocortcoids-mediated induction of CYP3A (Schuetz et al., 2000).
Although someone may argue that such knock-out animal study may cause some other compensating pathway; further extrapolating result from rodents is not scientifically reasonable. Hence the regulation role of GR in CYP3A4 expression is still debatable. On the other hand, since PXR has been demonstrated as a major steroid hormone nuclear receptor in regulation the CYP3A4 gene expression (Lehmann et al., 1998), an indirect evidence for the latter hypothesis could be supported by the interactive regulatory cross communication between GR and other nuclear receptors, especially PXR, CAR and RXR (Pascussi et al., 2000a; Pascussi et al., 2000b; Gerbal-Chaloin et al., 2002). It is highly possible that GR indirectly contributes to the inducible gene regulation of CYP3A4 by interacting and controlling the expression of PXR, CAR and RXR.
Indeed, in studies using human hepatocytes, dexamethasone has shown to enhance the PXR, CAR and RXR expression, leading to enhanced PXR-mediated CYP3A4 expression (Pascussi et al., 2000a; Pascussi et al., 2000b). Unfortunately, no convincing evidence has been provided in relation to the direct implication of GR in CYP3A4 gene induction. Furthermore, more complicated phenomenon has been observed recently using placental trophoblast cell line (Pavek et al., 2007). In this study, GR-mediated CYP3A4 induction indicates hepatocyte-specific regulation pattern and some other hepatocyte-specific transcription factors are required for the GR-CYP3A4 gene regulation process.
It is of my point that since most of the studies have been done in vitro using human hepatocytes, in vivo situation could be far more complex especially in human body. Clearer picture depicting the role of GR in CYP3A4 gene expression is intriguing and it will be extreme important in understanding the regulation mechanism of this crucial enzyme, which ultimately leads to better predictions of clinical important drug-drug interactions.
Role of GR: Cytochrome P450 2C9 & 2C19
In contrast to CYP3A4, CYP2C9 is secondly most abundant drug-metabolizing enzymes in human liver and accounts for the metabolism of a wide range of clinically important therapeutic agents, such as phenytoin, S-warfarin and some nonsteroidal anti-inflammatory drugs. Although a great amount of knowledge has been known about this enzyme including genetic polymorphism, pharmacology, etc, very little is known about the molecular mechanisms underlying the transcriptional regulation of CYP2C9. Specifically, it has been demonstrated that CYP2C9 is inducible by dexamethasone (DEX) in primary human hepatocytes and the role of GR related to this inducible CYP2C9 gene expression has been carefully investigated by Sabine and his coworkers (Gerbal-Chaloin et al., 2002).
In addition to the transcriptional regulation by hCAR and PXR, deletional analysis of CYP2C9 regulatory region in the presence or absence of cotransfected GR and directed mutagenesis studies have been carried out to characterize the location of the functional GRE in CYP2C9 regulatory region; Further gel shift assays prove the direct interaction between hGR with CYP2C9-GRE. These observations provide a convincing evidence for direct implication of GR in the inducible CYP2C9 expression and shed light for further understanding this crucial enzyme gene regulation. In stead of using human primary hepatocytes, some research group investigated the role of GR in the transcriptional regulation of CYP2C9 in placental cell line. Interestingly, unlike the hepatocytes, due to lack of hepatocyte-specific transcriptional factors, such as hepatocyte nuclear factor 4a (HNF4a), CYP2C9 is not inducible in this special placental cell line (Pavek et al., 2007). Similar observation seen in the aforementioned CYP3A4, which might indicates the tissue-specificity regulatory role of GR-CYP gene regulation.
CYP2C19 is also abundantly expressed in the liver and several clinically important agents
undergo CYP2C19-mediated oxidative metabolism including omeprazole, diazepam, etc. A high interindividual variability related to CYP2C19 expression has been observed, which may partially contributed by the nuclear receptor-regulated CYP2C19 gene expression. By examining the transcriptional regulation of CYP2C19, the functional GR and CAR response element have been identified in the CYP2C19 promoter and mutation of GRE abolishes DEX-induced CYP2C19 expression in human hepatocytes (Chen et al., 2003). This provides clear evidence showing the importance of GR in regulating CYP2C19 expression.
Role of GR: Cytochrome P450 2B6
The role of GR in the xenobiotic-induced expression of CYP2B in rodents has been shown as evidenced by several groups. For example, GREs have been located in mouse CYP2B10 and rat CYP2B2 (Jaiswal et al., 1990; Stoltz et al., 1998) and GR has been shown as a requirement for maximal induction of these 2 genes in rodents (Shaw et al., 1993; Honkakoski and Negishi, 1998). This arise the question of the role of GR in the regulation of human CYP2B6 expression.CYP2B6 is a member of Cytochrome P450 group and has been considered as playing minor role in drug metabolism.
But recent studies suggest the importance of CYP2B6 by taking into account of the fact that CYP2B6 actually involve in metabolizing about 25% of all the pharmaceutical agents. Notably, CYP2B6 is also inducible and hepatic expression is highly variable between individuals (Xie and Evans, 2001). Due to increased attention and urgence in understanding the molecular determinants of CYP2B6 regulation, the role of GR in the CYP2B6 regulation has been evaluated by several research groups. For example, by a study using primary human hepatocytes cotransfected of hGR and hPXR or hCAR with CYP2B6 reporter constructs
(Wang et al., 2003), GR seems to function synergistically with hPXR and hCAR to regulate the xenobiotic-induced CYP2B6 expression while GR alone dose not exert this effect in human hepatocytes. As previously mentioned about the role of GR in gene regulation, it again suggest that activated GR could act as a coactivator to enhance the hPXR and hCAR-mediated CYP2B6 expression.
Role of GR: phase II drug-metabolizing enzymes
Glucuronidation, sulfation, and glutathione conjugation are the three most important conjugation reactions in phase II drug metabolism. In addition to the essentiality of GR in phase I drug metabolizing enzymes that I summarized above, GR seems also play role in regulating these three phase II drug metabolizing enzymes. In a UDP-glucuronosyltransferase (UGT) 1A1 reporter gene study by Toru and his coworkers (Usui et al., 2006), a dose-dependent induction of UGT1A1 by DEX has been observed and co-expression of hGR in the transfected HepG2 cell line enhance the induction by 7-fold; Further treatment with GR antagonist RU486 inhibit the DEX-mediated UGT1A1 induction. The data suggest the important role of GR on the effective induction of UGT1A1 in cultured human hepatocytes.
In terms of human sulfotransferase (SULTs), unlike the rat SULT1A1gene that GR mediates the transactivation of this gene expression (Fang et al., 2003); the expression of human SULT1A1 is not affected by glucocorticoids treatment in primary human hepatocytes (Duanmu et al., 2002). On the other hand, human SULT1A3 gene is induced by glucocorticoids through a GR-mediated transactivation in human HepG2 cells and the GRE is identified for the SULT1A3 (Bian et al., 2007). However, human hydroxysteroid sulfotransferase (SULT2A1) gene expression is induced by glucocorticoids through a more complex nuclear receptor-mediated mechanism, with some involvement of GR while PXR is considered as playing a major role in SULT1A3 gene regulation (Duanmu et al., 2002). Glutathione S-transferase (GST) mediated detoxification of electrophilic chemicals is pivotal in preventing toxicity in human body. Unlike the rodent models, little is known about the role of GR in the GST gene regulation. Interestingly, some research conducted to evaluate the role of GR on GSTA2 expression (Falkner et al., 2001). In transfected HepG2 cells, activated GR repress the expression of GSTA2 with low concentration of DEX; while with high concentration of DEX, GSTA2 is inducible via a PXR-dependent mechanism. However, extrapolation of these results to human is not reliable and requires future studies.
In this review, some clinical important phase I and phase II drug-metabolizing enzymes are examined related to the role of GR in the gene transcriptional regulation in human. Notably, these enzymes play pivotal role in xenobiotic metabolism and nuclear receptor-mediated xenobiotic regulation to a large extent rely on the transcriptional regulation of these enzymes expression. Molecular mechanism underlying the gene regulation has been elusive as the role of nuclear receptors being characterized. GR, as the first cloned human steroid receptor, seems play a controversy role in terms of its relative contribution and regulation mechanisms in different phase I and phase II drug-metabolizing enzymes. Although this article mainly focus on research data in human, examinations of the species difference and in vitro- in vivo correlation are crucial given that significant amount of available information deal with rodent models. Carefully
investigating these results could help us better understand the complicated role of GR in drug metabolism and guide the clinical intervention.
Bamberger CM, Bamberger AM, de Castro M and Chrousos GP (1995) Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 95:2435-2441.
Bian HS, Ngo SY, Tan W, Wong CH, Boelsterli UA and Tan TM (2007) Induction of human sulfotransferase 1A3 (SULT1A3) by glucocorticoids. Life Sci 81:1659-1667.
Buckingham JC (2006) Glucocorticoids: exemplars of multi-tasking. Br J Pharmacol 147 Suppl 1:S258-268.
Chen Y, Ferguson SS, Negishi M and Goldstein JA (2003) Identification of constitutive androstane receptor and glucocorticoid receptor binding sites in the CYP2C19 promoter. Mol Pharmacol 64:316-324.
Duanmu Z, Locke D, Smigelski J, Wu W, Dahn MS, Falany CN, Kocarek TA and Runge-Morris M (2002) Effects of dexamethasone on aryl (SULT1A1)- and hydroxysteroid (SULT2A1)-sulfotransferase gene expression in primary cultured human hepatocytes. Drug Metab Dispos 30:997-1004.
Dvorak Z, Ulrichova J and Modriansky M (2005) Role of microtubules network in CYP genes expression. Curr Drug Metab 6:545-552.
El-Sankary W, Bombail V, Gibson GG and Plant N (2002) Glucocorticoid-mediated induction of CYP3A4 is decreased by disruption of a protein: DNA interaction distinct from the pregnane X receptor response element. Drug Metab Dispos 30:1029-1034.
Falkner KC, Pinaire JA, Xiao GH, Geoghegan TE and Prough RA (2001) Regulation of the rat glutathione S-transferase A2 gene by glucocorticoids: involvement of both the glucocorticoid and pregnane X receptors. Mol Pharmacol 60:611-619.
Fang HL, Shenoy S, Duanmu Z, Kocarek TA and Runge-Morris M (2003) Transactivation of glucocorticoid-inducible rat aryl sulfotransferase (SULT1A1) gene transcription. Drug Metab Dispos 31:1378-1381.
Gerbal-Chaloin S, Daujat M, Pascussi JM, Pichard-Garcia L, Vilarem MJ and Maurel P (2002) Transcriptional regulation of CYP2C9 gene. Role of glucocorticoid receptor and constitutive androstane receptor. J Biol Chem 277:209-217.
Hayashi R, Wada H, Ito K and Adcock IM (2004) Effects of glucocorticoids on gene transcription. Eur J Pharmacol 500:51-62.
Hollenberg SM, Weinberger C, Ong ES, Cerelli G, Oro A, Lebo R, Thompson EB, Rosenfeld MG and Evans RM (1985) Primary structure and expression of a functional human glucocorticoid receptor cDNA. Nature 318:635-641.
Honkakoski P and Negishi M (1998) Protein serine/threonine phosphatase inhibitors suppress phenobarbital-induced Cyp2b10 gene transcription in mouse primary hepatocytes. Biochem J 330 ( Pt 2):889-895.
Jaiswal AK, Haaparanta T, Luc PV, Schembri J and Adesnik M (1990) Glucocorticoid regulation of a phenobarbital-inducible cytochrome P-450 gene: the presence of a functional glucocorticoid response element in the 5'-flanking region of the CYP2B2 gene. Nucleic Acids Res 18:4237-4242.
Kumar R and Thompson EB (2005) Gene regulation by the glucocorticoid receptor: structure:function relationship. J Steroid Biochem Mol Biol 94:383-394.
Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT and Kliewer SA (1998) The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 102:1016-1023.
Lu NZ, Wardell SE, Burnstein KL, Defranco D, Fuller PJ, Giguere V, Hochberg RB, McKay L, Renoir JM, Weigel NL, Wilson EM, McDonnell DP and Cidlowski JA (2006) International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: glucocorticoid, mineralocorticoid, progesterone, and androgen receptors. Pharmacol Rev 58:782-797.
Ogg MS, Williams JM, Tarbit M, Goldfarb PS, Gray TJ and Gibson GG (1999) A reporter gene assay to assess the molecular mechanisms of xenobiotic-dependent induction of the human CYP3A4 gene in vitro. Xenobiotica 29:269-279.
Pascussi JM, Drocourt L, Fabre JM, Maurel P and Vilarem MJ (2000a) Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators. Mol Pharmacol 58:361-372.
Pascussi JM, Gerbal-Chaloin S, Drocourt L, Assenat E, Larrey D, Pichard-Garcia L, Vilarem MJ and Maurel P (2004) Cross-talk between xenobiotic detoxication and other signalling pathways: clinical and toxicological consequences. Xenobiotica 34:633-664.
Pascussi JM, Gerbal-Chaloin S, Fabre JM, Maurel P and Vilarem MJ (2000b) Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: consequences on cytochrome P450 gene regulation. Mol Pharmacol 58:1441-1450.
Pascussi JM, Jounaidi Y, Drocourt L, Domergue J, Balabaud C, Maurel P and Vilarem MJ (1999) Evidence for the presence of a functional pregnane X receptor response element in the CYP3A7 promoter gene. Biochem Biophys Res Commun 260:377-381.
Pavek P, Cerveny L, Svecova L, Brysch M, Libra A, Vrzal R, Nachtigal P, Staud F, Ulrichova J, Fendrich Z and Dvorak Z (2007) Examination of Glucocorticoid receptor alpha-mediated transcriptional regulation of P-glycoprotein, CYP3A4, and CYP2C9 genes in placental trophoblast cell lines. Placenta 28:1004-1011.
Schuetz EG, Schmid W, Schutz G, Brimer C, Yasuda K, Kamataki T, Bornheim L, Myles K and Cole TJ (2000) The glucocorticoid receptor is essential for induction of cytochrome P-4502B by steroids but not for drug or steroid induction of CYP3A or P-450 reductase in mouse liver. Drug Metab Dispos 28:268-278.
Shaw PM, Adesnik M, Weiss MC and Corcos L (1993) The phenobarbital-induced transcriptional activation of cytochrome P-450 genes is blocked by the glucocorticoid-progesterone antagonist RU486. Mol Pharmacol 44:775-783.
Stoltz C, Vachon MH, Trottier E, Dubois S, Paquet Y and Anderson A (1998) The CYP2B2 phenobarbital response unit contains an accessory factor element and a putative glucocorticoid response element essential for conferring maximal phenobarbital responsiveness. J Biol Chem 273:8528-8536.
Usui T, Kuno T, Ueyama H, Ohkubo I and Mizutani T (2006) Proximal HNF1 element is essential for the induction of human UDP-glucuronosyltransferase 1A1 by glucocorticoid receptor. Biochem Pharmacol 71:693-701.
Wang H, Faucette SR, Gilbert D, Jolley SL, Sueyoshi T, Negishi M and LeCluyse EL (2003) Glucocorticoid receptor enhancement of pregnane X receptor-mediated CYP2B6 regulation in primary human hepatocytes. Drug Metab Dispos 31:620-630.
Xie W and Evans RM (2001) Orphan nuclear receptors: the exotics of xenobiotics. J Biol Chem 276:37739-37742.